37 /100
MEDIUM RISK
Score updated May 30, 2026

SABS — SAB Biotherapeutics, Inc. Dilution Risk Tracker

Track SABS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SABS — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
20
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
25%
📉 Score Deterioration 40%
• Score rose 17 points recently (worsening)
💰 Capital Raise 18%
• Active ATM program with $75M remaining capacity
🔔 Track SABS — Get forecast alerts →

💹 Market Data

Market Cap$275.27M
Shares Outstanding76.46M
Float52.34M
Cash$107.39M
Debt$6.17M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 29.8% shares (2025Q4 vs prior)
48 institutional holders · 36.37M shares
#1 Vivo Capital, LLC 11.42M shares
#2 RA CAPITAL MANAGEMENT, L.P. 4.40M shares
#3 Commodore Capital LP 4.40M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest2.75M
Days to Cover1.8
% of Float5.2%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
4 INSIDER TRANSACTION Mar 25, 2026
424B5 ATM Mar 19, 2026
8-K 8K EVENT Mar 19, 2026
424B5 ATM Mar 17, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track SABS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SABS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: ADAG AIEV AIP ALLO ALOY
🔬 More Research for SABS
📊 SABS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 SABS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.